Insulet Long Term Debt 2010-2023 | PODD
Insulet long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
- Insulet long term debt for the quarter ending December 31, 2023 was $1.366B, a 0.57% decline year-over-year.
- Insulet long term debt for 2023 was $1.366B, a 0.57% decline from 2022.
- Insulet long term debt for 2022 was $1.374B, a 10.05% increase from 2021.
- Insulet long term debt for 2021 was $1.249B, a 19.65% increase from 2020.
| Insulet Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $1,366 |
| 2022 | $1,374 |
| 2021 | $1,249 |
| 2020 | $1,044 |
| 2019 | $888 |
| 2018 | $592 |
| 2017 | $566 |
| 2016 | $333 |
| 2015 | $172 |
| 2014 | $166 |
| 2013 | $119 |
| 2012 | $104 |
| 2011 | $109 |
| 2010 | $69 |
| 2009 | $89 |
| Insulet Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,366 |
| 2023-09-30 | $1,371 |
| 2023-06-30 | $1,369 |
| 2023-03-31 | $1,369 |
| 2022-12-31 | $1,374 |
| 2022-09-30 | $1,380 |
| 2022-06-30 | $1,385 |
| 2022-03-31 | $1,391 |
| 2021-12-31 | $1,249 |
| 2021-09-30 | $1,257 |
| 2021-06-30 | $1,235 |
| 2021-03-31 | $1,052 |
| 2020-12-31 | $1,044 |
| 2020-09-30 | $922 |
| 2020-06-30 | $910 |
| 2020-03-31 | $899 |
| 2019-12-31 | $888 |
| 2019-09-30 | $986 |
| 2019-06-30 | $607 |
| 2019-03-31 | $600 |
| 2018-12-31 | $592 |
| 2018-09-30 | $584 |
| 2018-06-30 | $577 |
| 2018-03-31 | $570 |
| 2017-12-31 | $566 |
| 2017-09-30 | $345 |
| 2017-06-30 | $341 |
| 2017-03-31 | $337 |
| 2016-12-31 | $333 |
| 2016-09-30 | $329 |
| 2016-06-30 | $176 |
| 2016-03-31 | $174 |
| 2015-12-31 | $172 |
| 2015-09-30 | $175 |
| 2015-06-30 | $175 |
| 2015-03-31 | $175 |
| 2014-12-31 | $166 |
| 2014-09-30 | $171 |
| 2014-06-30 | $175 |
| 2014-03-31 | $121 |
| 2013-12-31 | $119 |
| 2013-09-30 | $117 |
| 2013-06-30 | $112 |
| 2013-03-31 | $106 |
| 2012-12-31 | $104 |
| 2012-09-30 | $102 |
| 2012-06-30 | $99 |
| 2012-03-31 | $111 |
| 2011-12-31 | $109 |
| 2011-09-30 | $106 |
| 2011-06-30 | $104 |
| 2011-03-31 | $71 |
| 2010-12-31 | $69 |
| 2010-09-30 | $94 |
| 2010-06-30 | $92 |
| 2010-03-31 | $98 |
| 2009-12-31 | $89 |
| 2009-09-30 | $96 |
| 2009-06-30 | $83 |
| 2009-03-31 | $81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.984B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
| Stryker (SYK) | United States | $127.230B | 30.47 |
| Medtronic (MDT) | Ireland | $113.715B | 16.10 |
| Boston Scientific (BSX) | United States | $109.372B | 34.84 |
| EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.132B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
| ResMed (RMD) | United States | $32.315B | 30.34 |
| Terumo (TRUMY) | Japan | $26.460B | 37.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
| Baxter (BAX) | United States | $17.922B | 12.74 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
| BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
| Haemonetics (HAE) | United States | $4.815B | 23.82 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.103B | 12.44 |
| Envista Holdings (NVST) | United States | $3.288B | 13.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
| QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
| Neogen (NEOG) | United States | $2.905B | 27.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
| TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
| ICU Medical (ICUI) | United States | $2.589B | 22.85 |
| Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
| Warby Parker (WRBY) | United States | $1.600B | 0.00 |
| InMode (INMD) | Israel | $1.565B | 8.32 |
| Owens & Minor (OMI) | United States | $1.462B | 12.74 |
| AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| AtriCure (ATRC) | United States | $1.077B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
| Evolus (EOLS) | United States | $0.858B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| PetIQ (PETQ) | United States | $0.583B | 19.05 |
| TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
| Jin Medical (ZJYL) | China | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.486B | 30.43 |
| ZimVie (ZIMV) | United States | $0.463B | 39.49 |
| Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
| Cerus (CERS) | United States | $0.362B | 0.00 |
| Biote (BTMD) | United States | $0.362B | 8.34 |
| Zynex (ZYXI) | United States | $0.350B | 47.83 |
| MacroGenics (MGNX) | United States | $0.321B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
| Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
| Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.19 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 8.54 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.62 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |